杀疯了！引爆近1000亿！Arrowhead与Sarepta合作开发的siRNA药物绝了

谈思生物11-27

2024.11.27本文字数：655，阅读时长大约2分钟导读：在小核酸治疗领域，Arrowhead Pharmaceuticals与Sarepta Therapeutics达成的合作协议不仅覆盖了5款临床阶段和2款临床前管线，还可能涉及多达6个靶点的药物开发，总合作金额可能超过100亿美元。2024年11月26日，Arrowhead Pharmaceuticals与Sarepta ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2486102338?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-27 16:06","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2486102338","market":"us","top_or_hot":-1,"title":"杀疯了！引爆近1000亿！Arrowhead与Sarepta合作开发的siRNA药物绝了","media":"谈思生物","content":"<div>\n<p>2024.11.27本文字数：655，阅读时长大约2分钟导读：在小核酸治疗领域，Arrowhead Pharmaceuticals与Sarepta Therapeutics达成的合作协议不仅覆盖了5款临床阶段和2款临床前管线，还可能涉及多达6个靶点的药物开发，总合作金额可能超过100亿美元。2024年11月26日，Arrowhead Pharmaceuticals与Sarepta ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127164415a25948e3&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>杀疯了！引爆近1000亿！Arrowhead与Sarepta合作开发的siRNA药物绝了</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n杀疯了！引爆近1000亿！Arrowhead与Sarepta合作开发的siRNA药物绝了\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-27 16:06 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127164415a25948e3&s=b><strong>谈思生物</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2024.11.27本文字数：655，阅读时长大约2分钟导读：在小核酸治疗领域，Arrowhead Pharmaceuticals与Sarepta Therapeutics达成的合作协议不仅覆盖了5款临床阶段和2款临床前管线，还可能涉及多达6个靶点的药物开发，总合作金额可能超过100亿美元。2024年11月26日，Arrowhead Pharmaceuticals与Sarepta ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127164415a25948e3&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127164415a25948e3&s=b","article_id":"2486102338","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127164415a25948e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2486102338","pubTimestamp":1732694777,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"2024年11月26日，Arrowhead Pharmaceuticals与Sarepta Therapeutics宣布达成一项合作协议。根据合作协议，Arrowhead Pharmaceuticals将获得5亿美元的预付款和3.25亿美元的股权投资。此外，在未来五年内，Arrowhead还将收到2.5亿美元的额外付款，以及3亿美元与近期临床试验患者入组相关的里程碑付款。在宣布合作消息的当天，Arrowhead Pharmaceuticals的股价上涨了12%，其市值达到了26亿美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK4588":"碎股","CNS":"科恩-斯蒂尔斯金融","BK4135":"资产管理与托管银行","ARWR":"Arrowhead Research Corporation"},"translate_title":"Killing mad! Detonated nearly 100 billion! The siRNA drug developed by Arrowhead and Sarepta is absolutely complete","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNS":1,"ARWR":0.9},"content_text":"2024.11.27本文字数：655，阅读时长大约2分钟导读：在小核酸治疗领域，Arrowhead Pharmaceuticals与Sarepta Therapeutics达成的合作协议不仅覆盖了5款临床阶段和2款临床前管线，还可能涉及多达6个靶点的药物开发，总合作金额可能超过100亿美元。2024年11月26日，Arrowhead Pharmaceuticals与Sarepta Therapeutics宣布达成一项合作协议。该合作将涵盖5个处于临床阶段和2个处于临床前阶段的管线项目，以及针对罕见疾病、遗传性肌肉疾病、中枢神经系统（CNS）和肺部疾病的siRNA药物开发，最多涉及6个靶点。根据合作协议，Arrowhead Pharmaceuticals将获得5亿美元的预付款和3.25亿美元的股权投资。此外，在未来五年内，Arrowhead还将收到2.5亿美元的额外付款，以及3亿美元与近期临床试验患者入组相关的里程碑付款。公司还有资格获得高达103亿美元的未来里程碑付款（每个项目约17.2亿美元），并且将获得一定比例的销售分成。按最新汇率计算，以上金额合计约合人民币846亿元。合作涉及的管线包括ARO-DUX4、ARO-DM1、ARO-MMP7、ARO-ATXN2、ARO-HTT、ARO-ATXN1和ARO-ATXN3等项目。在宣布合作消息的当天，Arrowhead Pharmaceuticals的股价上涨了12%，其市值达到了26亿美元。近几年，小核酸技术领域取得了显著进展，特别是在肝脏靶向治疗方面已经扩展到常见疾病，其他组织靶向技术也在不断实现新的突破。在资本市场，行业领头羊Alnylam的市值已突破300亿美元，超越了mRNA领域的领军企业Moderna和BioNTech。专注于肌肉靶向的AOC公司Avidity的市值已达到50亿美元，而Dyne的市值也达到了30亿美元。大型制药公司（MNC）和生物技术公司（Biotech）也开始积极布局siRNA领域，例如诺和诺德以33亿美元收购Dicerna，以及诺华与舶望生物达成超过40亿美元的交易。小核酸治疗领域正展现出多样化的靶点开发和多样化的递送技术的繁荣景象。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486102338"}